# Microbiome of Depression & Treatment Response to Citalopram

> **NCT02330068** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 34 (actual)

## Conditions studied

- Major Depressive Disorder, Bipolar I and Bipolar II

## Interventions

- **DRUG:** citalopram

## Key facts

- **NCT ID:** NCT02330068
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330068, "Microbiome of Depression & Treatment Response to Citalopram". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02330068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*